Dentsply Sirona appoints Matthew E. Garth as CFO, effective May 30, 2025, to enhance financial strategy and growth.

Dentsply Sirona Q1 2025 insights: Growth in key regions, margin expansion, and innovation-driven strategies.

Dentsply Sirona Inc. XRAY stock surged about 15% Thursday, and was on track for the biggest single-day advance since 2019 after posting earnings that topped estimates.

Dental products company Dentsply Sirona (NASDAQ:XRAY) announced better-than-expected revenue in Q1 CY2025, but sales fell by 7.8% year on year to $879 million. The company’s full-year revenue ...

VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM)(FSE: ZSB) (OTC: SRBCF) (“Sirona”), a biotechnology company specializing cosmetic ingredients and new ...

Sirona Laboratories will be established in Luxembourg and will be responsible for the exclusive distribution of anti-aging products based on the TFC-1326 active ingredient.

(FSE: ZSB) (OTC: SRBCF) (“Sirona”), a biotechnology company specializing cosmetic ingredients and new drug discoveries, is pleased to announce the successful execution of a strategic investment ...

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a leading company in the dental equipment and supplies industry with a market capitalization of $3.1 billion, has entered into a bridge loan agreement to ...

Dentsply Sirona Q4 earnings miss estimates with a 10% sales drop, and the company forecasts lower 2025 sales.

Full transcript - Dentsply Sirona Inc (XRAY) Q4 2024: Josh, Conference Operator: Good day and thank you for standing by. Welcome to the Q4 twenty twenty four Dentsply Sirona Earnings Conference Call.

In a surprising turn, Sirona’s founders have bought back the women’s wellness brand from Good Glamm Group following a disputed sale that was finally concluded in October.

The founders of feminine hygiene brand Sirona, Deep and Mohit Bajaj, have repurchased their company from content-to-commerce unicorn The Good Glam Group for an undisclosed amount.